3rd Annual Biomarkers Congress
14th & 15th May 2008, The Midland Hotel, Manchester, UK
3rd Annual Biomarkers Congress is administered by Osney Media.
Speakers

Our  

Our carefully researched speaker programmes are further enhanced by the opportunity for the delegates and speakers to discuss topics of interest in more detail during round table discussions. This means that the attendees not only benefit from the expertise of the high level speaker panel but also that of the other delegates.

 

If you have a cutting edge case study or a presentation and would like to join the speaker panel at one of our events, please contact Cerlin Roberts at c.roberts@oxfordglobal.co.uk

Speakers include:





Dr. Iman El-Hariry, Group Director, Oncology MDC, Europe, GlaxoSmithKline R&D
Dr. Dorothee Foernzler, Biomarker - Experimental Medicine Leader F.Hoffmann-La Roche
Dr. Stuart Freeman, Director of Worldwide Toxicology, GlaxoSmithKline UK
Dr. Nicolas Frey, Head of the Modeling and Simulation Group, F. Hoffmann-La Roche
Dr. William Gallagher, Associate Professor, University College Dublin
Antony Gee, Head of PET and Radiotracer Development, GlaxoSmithKline
Dr. Martin Grigorov, Head of Bioinformatics, Nestle Research Centre
Dr. Ehud Hauben, Head of Molecular Medicine Unit, Clinical Sciences and Biomarkers, Exploratory Medicine, Merck Serono Research
Dr. Hermann-Josef Huss, Head, Data Acquisition & Management Europe & Overseas, Bayer Healthcare
Dr. Jeanne Kehren, Head of Integrated Analysis, Biomarker Development, Novartis Pharma AG
Dr. Bernard Leblanc, Head, Regulatory Submissions & External Relations Safety Sciences, Pfizer
Dr. Ruth March, Personalized Healthcare Science & Technology Director, Personalized Healthcare Team, Astra Zeneca UK
Prof. Dario Neri, Professor, Department of Chemistry and Applied Biosciences ETH Zurich
Dr. Martin Oleksiewicz, Team Leader, Molecular Toxicology, Novo Nordisk A/S
Dr. Koustubh Ranade, Director, Pharmacogenomics & Human Genetics, Pharmaceutical Research Institute, Bristol-Myers Squibb Company
Dr. Bjorn Riefke, Head Laboratory Diagnostics Non-Clinical Drug Safety, Bayer Healthcare
Dr. Ronenn Roubenoff, MD, Senior Director, Immunology Medical Research, Biogen Idec, Inc.
Dr. Hugh Salter, Associate Director, Pharmacogenomics, Astra Zeneca
Dr. Michael Shi, Director and Biomarker Project Leader of Exploratory Oncology Development, Novartis
Dr. Magnus Sjogren, Associate Professor, Psychiatrist, Director Clinical Research CNS, N.V. Organon
Dr. Thomas Steger-Hartmann, Head Lab Diagnostics Experimental Toxicology, Schering AG
Dr. Detlef Stiller, Head, Invivo Imaging, Boehringer Ingelheim Germany
Dr. Stefan Sultana, Translational Medicine Leader for GU Therapeutic Area, Pfizer
Jean Tessier, Clinical Imaging Scientist, Discovery Medicine, Astra Zeneca
Dr. Alain van Gool, Director Genomics & Proteomics N.V. Organon
Dr. George Wensing, Head, Pharmacodynamics, Clinical Pharmacology, Bayer Healthcare
Dr. Paul Whiting, Head of Biomarkers and Translational Biology, Discovery Biology, Pfizer
Home | Biomarkers 2008 | Programme | Event Format | Speakers | Delegates | Solution Providers | Media Partners | Press Centre | Testimonials | Venue | Organisers | Other Events | Contact | Book Online | 
© 3rd Annual Biomarkers Congress